Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
FLML: Stock Quote & Summary Data
1.63%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | N/A |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 53,328 |
| Previous Close | $ 7.36 |
| 52 Wk High / Low | $ 9.94 / $ 3.60 |
| Shares Outstanding | 24,225,000 |
| Market Value | $ 181,203,000 |
| P/E Ratio | NE |
| Forward P/E (1yr) | N/A |
| Earnings Per Share | $ -0.35 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 0.27 |
| NASDAQ Official Open Price: | $ 7.44 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 7.48 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About FLML?
Ask your question about about Flamel Technologies S.A. (FLML) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
We are a biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications. Our Medusa nanoparticulate technology is designed to deliver therapeutic proteins, peptides and other large and small molecules injected subcutaneously. Our Micropump technology is a multiparticulate technology for oral administration of small molecule drugs with applications in controlled-release, taste-masking and bioavailability enhancement. Our Trigger-Lock® technology is an adaptation of Micropump designed to prevent the misuse of medications subject to abuse and to avoid dose dumping in the presence of alcohol. Our expertise in polymer science has also been instrumental in the development of a photochromic eyeglass lens product that was launched by Corning in 1999. ... More ...
Links to all Flamel Technologies S.A. (FLML) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for FLML |
||
|
4-Star Stocks on the Upswing - The Motley Fool 11/19/2009 2:30PM |
||
|
Flamel Technologies Q3 09 Earnings Conference Call At 8:30 AM ET - RTT News 11/16/2009 7:34AM |
||
|
Flamel Tech.Q3 Loss Widens - Quick Facts - RTT News 11/16/2009 7:33AM |
||
|
Flamel Technologies Announces Third Quarter 2009 Results; Additional New Projects; Cash Increases from $45.1 to $48.8 million - Business Wire 11/16/2009 7:00AM |
||
|
Flamel Technologies Announces Projected Release Date of Third Quarter Results; Conference Call - Business Wire 11/04/2009 4:15PM |
||
|
Flamel Says Pfizer To License Medusa Technology For The Development Of An Already-marketed Therapeutic Protein - Quick Facts - RTT News 11/04/2009 2:20PM |
||
|
Flamel Technologies Announces Licensing Agreement with Pfizer - Business Wire 11/04/2009 8:00AM |
